Zhejiang Haisen Pharmaceutical Co., Ltd. (SHE:001367)

SHE:001367 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 5, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Market Capitalization	3,557	3,300	2,796	2,989	-	-
Market Cap Growth	22.68%	18.01%	-6.46%	-	-	-
Enterprise Value	2,495	2,300	1,832	2,063	-	-
Last Close Price	23.66	21.95	18.30	19.69	-	-
PE Ratio	26.87	24.29	22.82	28.56	-	-
PS Ratio	6.83	6.20	5.93	7.52	-	-
PB Ratio	2.33	2.21	2.08	2.39	-	-
P/TBV Ratio	2.53	2.40	2.11	2.43	-	-
P/FCF Ratio	72.75	131.00	27.31	128.99	-	-
P/OCF Ratio	21.78	18.60	16.73	37.08	-	-
EV/Sales Ratio	4.79	4.32	3.89	5.19	-	-
EV/EBITDA Ratio	15.08	14.00	13.87	18.18	-	-
EV/EBIT Ratio	17.73	16.13	15.70	20.45	-	-
EV/FCF Ratio	51.02	91.29	17.89	89.04	-	-
Debt / Equity Ratio	0.01	0.01	0.01	0	0.00	0.00
Debt / EBITDA Ratio	0.05	0.04	0.06	0.00	0.01	0.01
Debt / FCF Ratio	0.15	0.30	0.08	0.01	0.01	0.02
Net Debt / Equity Ratio	-0.70	-0.70	-0.76	-0.75	-0.52	-0.57
Net Debt / EBITDA Ratio	-6.48	-6.41	-7.77	-8.31	-2.08	-1.74
Net Debt / FCF Ratio	-21.72	-41.83	-10.02	-40.72	-4.50	-2.77
Asset Turnover	0.33	0.34	0.33	0.42	0.81	0.93
Inventory Turnover	2.51	2.60	2.05	1.57	2.15	2.47
Quick Ratio	13.32	10.06	9.33	12.90	3.53	2.46
Current Ratio	14.66	11.01	10.31	14.95	5.35	3.51
Return on Equity (ROE)	9.19%	9.58%	9.45%	12.18%	25.91%	29.36%
Return on Assets (ROA)	5.60%	5.72%	5.16%	6.62%	12.59%	15.61%
Return on Invested Capital (ROIC)	27.06%	32.62%	32.36%	33.13%	48.12%	61.17%
Return on Capital Employed (ROCE)	9.10%	9.40%	8.60%	8.00%	21.80%	28.00%
Earnings Yield	3.76%	4.12%	4.38%	3.50%	-	-
FCF Yield	1.37%	0.76%	3.66%	0.78%	-	-
Dividend Yield	0.49%	0.53%	0.93%	1.16%	-	-
Payout Ratio	13.06%	12.84%	27.74%	-	0.66%	17.48%
Buyback Yield / Dilution	-0.43%	-2.15%	-9.03%	-22.74%	0.02%	-
Total Shareholder Return	0.06%	-1.62%	-8.10%	-21.58%	0.02%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.